Men | Women | |||||||
---|---|---|---|---|---|---|---|---|
Variable | N (%) | TBS Least Square Mean (%95CLI) |
P value for trend |
N (%) | TBS Least Square Mean (%95CLI) |
P value for trend |
P value for Interaction |
|
Age (years) | N= 369 | 0.19 | N= 303 | 0.017* | 0.15 | |||
50–54 | 50 (13.55%) | 1.333 (1.291 – 1.376) | ||||||
55–59 | 66 (17.89%) | 1.314 (1.270 – 1.357) | 83 (27.39%) | 1.294 (1.264 – 1.325) | ||||
60–64 | 116 (31.44%) | 1.294 (1.252 – 1.336) | 102 (33.66%) | 1.271 (1.242 – 1.301) | ||||
65–69 | 90 (24.39%) | 1.302 (1.259 – 1.345) | 78 (25.74%) | 1.267 (1.235 – 1.299) | ||||
70–74 | 29 (7.86%) | 1.291 (1.239 – 1.344) | 29 (9.57%) | 1.241 (1.201 – 1.282) | ||||
75–79 | 13 (3.52%) | 1.291 (1.229 – 1.353) | 10 (3.30%) | 1.233 (1.180 – 1.285) | ||||
80–84 | 5 (1.36%) | 1.341 (1.253 – 1.429) | 1 (0.33%) | 1.309 (1.152 – 1.465) | ||||
Race/Ethnicity | N= 364 | 0.62 | N= 297 | 0.16 | 0.86 | |||
Non-Hispanic White |
294 (80.77%) | 1.310 (1.270 – 1.349) | 255 (85.86%) | 1.294 (1.260 – 1.328) | ||||
African American/Black |
42 (11.54%) | 1.308 (1.261 – 1.356) | 16 (5.39%) | 1.247 (1.197 – 1.298) | ||||
BMI (kg/m2) | N= 369 | <0.001* | N= 303 | <0.001* | 0.008* | |||
<18.5 | 1 (0.27%) | 1.351 (1.173 – 1.528) | 3 (0.99%) | 1.280 (1.185 – 1.376) | ||||
18.5–24.9 | 74 (20.05%) | 1.389 (1.361 – 1.417) | 113 (37.29%) | 1.310 (1.274 – 1.345) | ||||
25–29.9 | 206 (55.83%) | 1.349 (1.329 – 1.370) | 104 (34.32%) | 1.281 (1.246 – 1.317) | ||||
30–34.9 | 76 (20.60%) | 1.299 (1.273 – 1.326) | 72 (23.76%) | 1.240 (1.203 – 1.276) | ||||
35–37.0 | 12 (3.25%) | 1.159 (1.106 – 1.212) | 11 (3.63%) | 1.236 (1.180 – 1.293) | ||||
History of fragility fracture at baseline |
N= 360 | 0.077 | N= 295 | 0.43 | 0.53 | |||
No | 341 (94.72%) | 1.312 (1.271 – 1.353) | 260 (88.14%) | 1.272 (1.234 – 1.310) | ||||
Yes | 19 (5.28%) | 1.273 (1.215 – 1.331) | 35 (11.86%) | 1.260 (1.213 – 1.307) | ||||
Diabetes | N= 365 | 0.008* | N= 299 | 0.82 | 0.099 | |||
No | 322 (88.22%) | 1.318 (1.276 – 1.360) | 280 (93.65%) | 1.260 (1.223 – 1.298) | ||||
Yes | 43 (11.78%) | 1.278 (1.231 – 1.324) | 19 (6.35%) | 1.256 (1.206 – 1.306) | ||||
Multivitamin use |
N= 342 | 0.80 | N= 292 | 0.77 | 0.63 | |||
No | 177 (51.75%) | 1.310 (1.266 – 1.354) | 177 (60.62%) | 1.269 (1.229 – 1.309) | ||||
Yes | 165 (48.25%) | 1.308 (1.265 – 1.350) | 115 (39.38%) | 1.272 (1.230 – 1.314) | ||||
Caffeine use | N= 343 | 0.30 | N= 291 | 0.93 | 0.26 | |||
Never | 31 (9.04%) | 1.289 (1.240 – 1.338) | 23 (7.90%) | 1.277 (1.225 – 1.329) | ||||
>0- ⩽1 servings/day |
103 (30.03%) | 1.316 (1.272 – 1.360) | 58 (19.93%) | 1.273 (1.229 – 1.317) | ||||
>1- ⩽2.5 servings/day |
109 (31.78%) | 1.316 (1.270 – 1.362) | 99 (34.02%) | 1.265 (1.221 – 1.308) | ||||
>2.5- ⩽3.5 servings/day |
58 (16.91%) | 1.334 (1.284 – 1.384) | 84 (28.87%) | 1.268 (1.223 – 1.314) | ||||
>3.5 servings/day |
42 (12.24%) | 1.322 (1.270 – 1.374) | 27 (9.28%) | 1.261 (1.213 – 1.309) | ||||
Smoking status | N= 366 | 0.74 | N= 302 | 0.092 | 0.12 | |||
Never | 181 (49.45%) | 1.310 (1.268 – 1.353) | 161 (53.31%) | 1.278 (1.240 – 1.316) | ||||
Past | 161 (43.99%) | 1.305 (1.262 – 1.348) | 123 (40.73%) | 1.266 (1.226 – 1.306) | ||||
Current | 24 (6.56%) | 1.319 (1.264 – 1.375) | 18 (5.96%) | 1.237 (1.186 – 1.289) | ||||
Alcohol use | N= 343 | 0.018* | N= 291 | 0.24 | 0.28 | |||
Never / Rarely | 62 (18.08%) | 1.293 (1.249 – 1.337) | 56 (19.24%) | 1.252 (1.207 – 1.297) | ||||
1–3/ month | 13 (3.79%) | 1.336 (1.272 – 1.399) | 30 (10.31%) | 1.261 (1.213 – 1.308) | ||||
1/ week | 34 (9.91%) | 1.306 (1.255 – 1.357) | 43 (14.78%) | 1.281 (1.236 – 1.326) | ||||
2–4/ week | 64 (18.66%) | 1.320 (1.273 – 1.367) | 51 (17.53%) | 1.269 (1.225 – 1.313) | ||||
5–6/ week | 40 (11.66%) | 1.340 (1.290 – 1.390) | 31 (10.65%) | 1.268 (1.217 – 1.318) | ||||
1 / day | 53 (15.45%) | 1.333 (1.285 – 1.382) | 40 (13.75%) | 1.279 (1.230 – 1.328) | ||||
2–3/ day | 61 (17.78%) | 1.314 (1.267 – 1.362) | 36 (12.37%) | 1.301 (1.252 – 1.351) | ||||
4–5/ day | 11 (3.21%) | 1.285 (1.218 – 1.353) | 3 (1.03%) | 1.245 (1.126 – 1.363) | ||||
6+ /day | 5 (1.46%) | 1.210 (1.122 – 1.299) | 1 (0.34%) | 1.223 (1.062 – 1.385) | ||||
Total MET- hrs/week categories |
N= 368 | 0.10 | N= 301 | 0.35 | 0.54 | |||
1st tertile (0– 13.71) |
113 (30.71%) | 1.301 (1.259 – 1.343) | 110 (36.54%) | 1.265 (1.226 – 1.304) | ||||
2nd tertile (13.72– 32.48) |
129 (35.05%) | 1.308 (1.265 – 1.352) | 94 (31.23%) | 1.281 (1.240 – 1.322) | ||||
3rd tertile (⩾32.49) |
126 (34.24%) | 1.326 (1.282 – 1.369) | 97 (32.23%) | 1.277 (1.236 – 1.319) | ||||
SSRI use | N= 362 | 0.013* | N= 300 | 0.80 | 0.025* | |||
No | 339 (93.65%) | 1.310 (1.269 – 1.351) | 270 (90.00%) | 1.271 (1.233 – 1.309) | ||||
Yes | 23 (6.35%) | 1.260 (1.204 – 1.316) | 30 (10.00%) | 1.267 (1.218 – 1.316) | ||||
Falls in the past year |
N= 345 | 0.49 | N= 293 | 0.20 | ||||
None | 293 (84.93%) | 1.311 (1.268 – 1.353) | 226 (77.13%) | 1.267 (1.228 – 1.307) | ||||
One fall | 42 (12.17%) | 1.287 (1.238 – 1.337) | 50 (17.06%) | 1.265 (1.219 – 1.310) | ||||
Two falls | 6 (1.74%) | 1.306 (1.222 – 1.390) | 9 (3.07%) | 1.324 (1.260 – 1.389) | ||||
Three falls | 4 (1.16%) | 1.290 (1.191 – 1.389) | 8 (2.73%) | 1.259 (1.191 – 1.328) |